STERIS plc (STE) Financial Statements
Historical financial data — 30 statements covering FY2019–FY2026
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring t...
STERIS plc's revenue increased 8.7% year over year, from $5.46B to $5.94B.
Net income increased 27.3% over the same period, from $614.6M to $782.3M.
Over the 7-year period from FY2019 to FY2026, revenue grew by 113% in total.
Total debt remained relatively stable at $2.09B.
The debt-to-equity ratio stands at 0.29, indicating a conservative leverage profile.
Operating cash flow grew 16.8% to $1.34B.
STERIS plc maintains a healthy net profit margin of 13.2%.
Recent Financial Statements
Quarterly figures are standalone quarters, de-cumulated from YTD filings (Q4 = FY − Q3 YTD when not reported).
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2025 | $1.33B+3.9% | $150.0M | $578.8M | $219.7M | $250.7M | $10.24B | $2.24B | $6.59B |
| Q3 FY2025 | $1.37B+3.1% | $173.5M | $610.3M | $245.3M | $332.8M | $10.01B | $2.16B | $6.42B |
| Q4 FY2025 | $1.48B+8.0% | $145.7M | $641.2M | $216.2M | $260.8M | $10.15B | $2.04B | $6.60B |
| Q1 FY2026 | $1.39B-6.0% | $177.4M | $628.0M | $246.0M | $420.0M | $10.40B | $1.90B | $6.96B |
| Q2 FY2026 | $1.46B+5.0% | $191.8M | $645.9M | $265.8M | $287.8M | $10.41B | $1.90B | $7.01B |
| Q3 FY2026 | $1.50B+2.5% | $192.9M | $655.5M | $273.2M | $298.2M | $10.59B | $1.90B | $7.15B |
| Q4 FY2026 | $1.59B+6.2% | $220.2M | $697.1M | $316.8M | $335.4M | $10.74B | $2.09B | $7.20B |
| Q1 FY2027 | $1.49B-6.0% | $200.1M | $684.2M | $285.8M | $367.1M | $10.74B | $2.04B | $7.22B |
Balance Sheet Summary (Q1 FY2027)
STERIS plc (STE) Financial Statements & Revenue History
STERIS plc (STE) is a US-listed stock operating in the Healthcare sector, specifically the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry trading at $222.66 with a market capitalization of $22. This page provides 30 historical financial statements for STERIS plc, including income statement, balance sheet, and cash flow data across multiple reporting periods. Most recently, STERIS plc reported revenue of $5.9 billion, representing 8.7% year-over-year growth. The net profit margin of 13.2% indicates moderate profitability. The debt-to-equity ratio of 0.29 shows conservative leverage.
STE Income Statement, Balance Sheet & Cash Flow
The financial statements table above shows STERIS plc's revenue, net income, gross profit, EBIT, operating cash flow, total assets, total debt, and shareholders' equity across the most recent reporting periods. Year-over-year growth rates help identify whether STE is accelerating or decelerating in terms of top-line revenue and bottom-line profitability.
- Revenue trend: Track STE's top-line growth across quarters and fiscal years to identify acceleration or deceleration in the business.
- Profitability: Net income and gross profit margins reveal how efficiently STERIS plc converts revenue into earnings.
- Balance sheet health: Total assets, liabilities, debt, and equity provide a snapshot of STE's financial position and leverage.
- Cash flow: Operating cash flow shows how much cash the business generates from its core operations, which is critical for funding dividends, buybacks, and growth.
How to Use STE Financial Data
Investors use STERIS plc's financial statements to assess the company's financial health, growth trajectory, and valuation. Key metrics to focus on include:
- Revenue growth rate: Consistent double-digit revenue growth suggests a strong business; declining revenue may signal competitive pressure.
- Net profit margin: Higher margins indicate a more efficient business with pricing power. Compare STE's margins to sector peers for context.
- Debt levels: High debt-to-equity ratios increase financial risk, especially in rising-rate environments. Low debt provides flexibility.
- Valuation multiples: See how STE's P/E, P/S, and EV/EBITDA ratios compare to historical levels.
- Full analysis: View STE's financial health score, earnings, and pre-market pricing.
Financial data is sourced from STERIS plc's SEC filings (10-K, 10-Q) via Polygon.io and Finnhub.STE trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.